BioMarCare Receives $1M Strategic Investment From Micromedic

Hadasit Bio-Holdings Ltd. a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel’s foremost medical research center, today announced that one of its portfolio company’s, BioMarCare, which does cancer diagnostics, received a $1 million strategic investment from Micromedic Ltd. with an option to invest an additional $1 million.